Results 1 to 10 of about 3,023 (195)

Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate [PDF]

open access: yesPharmaceutics, 2022
This study aimed to prepare mucus-penetrating inhalable microparticles for dry powder inhalers and to evaluate their applicability in an asthma-induced rat model. Microparticles were prepared from water solutions containing tiotropium bromide, L-leucine,
Yong-Bin Kwon   +5 more
doaj   +3 more sources

Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction [PDF]

open access: yesInternational Journal of COPD, 2017
Dimitrios Toumpanakis,1,2 Konstantinos Loverdos,1,2 Vassiliki Tzouda,1,2 Vyronia Vassilakopoulou,1,2 Eleni Litsiou,1,2 Christina Magkou,3 Vassiliki Karavana,1,2 Michael Pieper,4 Theodoros Vassilakopoulos1,2 1First Critical Care Department, Pulmonary ...
Toumpanakis D   +8 more
doaj   +4 more sources

Impact of Long-Term Tiotropium Bromide Therapy on Annual Lung Function Decline in Adult Patients with Cystic Fibrosis. [PDF]

open access: yesPLoS ONE, 2016
Chronic lung disease is the leading cause of death in patients with Cystic Fibrosis (CF) and is often treated with bronchodilators. It is not known whether long-term tiotropium bromide treatment may have a positive impact on lung function.This ...
Claudia Brandt   +5 more
doaj   +3 more sources

Effect of Tiotropium Bromide on Airway Inflammation and Programmed Cell Death 5 in a Mouse Model of Ovalbumin-Induced Allergic Asthma [PDF]

open access: yesCanadian Respiratory Journal, 2019
Rationale. We previously demonstrated increased expression of programmed cell death 5 (PDCD5) in asthmatic patients and ovalbumin-induced allergic asthma.
Juan Wang   +3 more
doaj   +3 more sources

Tiotropium bromide as adjunct therapy in children with asthma: a clinical experience [PDF]

open access: yesAllergy, Asthma & Clinical Immunology, 2021
Background The Global Initiative for Asthma has only recently added tiotropium bromide as adjunct controller therapy in severe asthma (Step 4 or 5) in adults (2015) and children (2019). Although not yet approved for pediatric use by Health Canada, it has
Zainab Ridha   +6 more
doaj   +2 more sources

Tiotropium Bromide Has a More Potent Effect Than Corticosteroid in the Acute Neutrophilic Asthma Mouse Model [PDF]

open access: yesTuberculosis and Respiratory Diseases, 2022
Background Neutrophilic asthma (NeuA) is usually resistant to corticosteroids. Tiotropium bromide (TIO) is a bronchodilator that is used as an add-on therapy to inhaled corticosteroid and long-acting β2 agonist in asthma treatment.
Tai Joon An   +3 more
doaj   +2 more sources

Legal demands of the tiotropium bromide for treatment of chronic obstructive pulmonary disease and their financial impact for the State of Paraná, Brazil [PDF]

open access: yesEinstein (São Paulo), 2020
Objective To analyze the legal demands of tiotropium bromide to treat chronic obstructive pulmonary disease. Methods We included secondary data from the pharmaceutical care management systems made available by the Paraná State Drug Center.
Renata Szpak   +4 more
doaj   +2 more sources

Expression of Muscarinic Receptors and the Effect of Tiotropium Bromide in Aged Mouse Model of Chronic Asthma [PDF]

open access: yesTuberculosis and Respiratory Diseases, 2019
Background Efficacy and safety of tiotropium bromide, a muscarinic receptor antagonist, in treatment of asthma have been reported. However, its effect on airway remodeling in chronic asthma of the elderly has not been clearly verified.
Ji Young Kang, M.D., Ph.D.   +6 more
doaj   +2 more sources

Efficiency of tiotropium bromide in patients with severe persistent bronchial asthma in clinical practice

open access: yesActa Biomedica Scientifica, 2018
The aim of the study was to investigate the effectiveness of tiotropium bromide in patients with severe persistent asthma under conditions of real clinical practice.
A. F. Ivanov, B. A. Chernyak
doaj   +3 more sources

A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS) [PDF]

open access: yesTrials
Background Despite the fundamental progress in hematopoietic stem cell transplant, this treatment is also associated with complications. Graft-versus-host disease is a possible complication of HSCT.
Naeemeh Dini   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy